Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shensong Yangxin capsule for sinus bradycardia with premature ventricular contractions
ChiCTR-TRC-12002504Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of shensong yangxin capsule in Sinus bradycardia (SB) and Premature ventricular complexes (PVC) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: PVC number and Average heart rate. Started May 2012; status: completed.
02
Drugs
shensong yangxin capsule
03
Conditions
Sinus bradycardia (SB)Premature ventricular complexes (PVC)
Beyond the preview
Go deeper on ChiCTR-TRC-12002504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002504.